Records 1 - 30
| Computed tomography-guided lung biopsy for molecular tests: a meta-analysis.
Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery 2022 Jun 19 (2): 96-101.
Zhang Jian-Hua, Xia Feng-Fei, Yang Xiao-Shan, Li
| Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis.
ESMO open 2022 Jun 7 (3): 100511.
Yoshino T, Van Cutsem E, Li J, Shen L, Kim T W, Sriuranpong V, Xuereb L, Aubel P, Fougeray R, Cattan V, Amellal N, Ohtsu A, Mayer R
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer.
Targeted oncology 2022 Jun .
Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H
| Systematic review of tumour budding and association with common mutations in patients with colorectal cancer.
Critical reviews in oncology/hematology 2021 Oct 167 103490.
Hatthakarnkul Phimmada, Quinn Jean A, Matly Amna Ahmed Mohemmd, Ammar Aula, van Wyk Hester C, McMillan Donald C, Edwards Joan
| Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases.
American journal of surgery 2021 Sep .
Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Pathology, research and practice 2021 Jul 224 153551.
Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih
| Efficacy of immune checkpoint inhibitors in the treatment of non-small cell lung cancer patients with different genes mutation: A meta-analysis.
Medicine 2021 Mar 100 (10): e19713.
Zhang Rui, Zhu Jing, Liu Ying, Xin Ying, Wang Ying, Niu Kai, Wei Huafa
| Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis.
Thoracic cancer 2021 Feb .
Kobayashi Nobuaki, Katakura Seigo, Kamimaki Chisato, Somekawa Kohei, Fukuda Nobuhiko, Tanaka Katsushi, Watanabe Keisuke, Horita Nobuyuki, Hara Yu, Piao Hongmei, Kaneko Takes
| KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis.
Caspian journal of internal medicine 2020 11 (4): 355-369.
Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav
| Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
BioMed research international 2020 2020 2380124.
Fan Kui, Zhang Chuan-Long, Qi Yuan-Fu, Dai Xin, Birling Yoann, Tan Zhao-Feng, Cao Fa
| Impact of KRAS mutation status on outcomes of metastatic colorectal cancer treated with anti-angiogenic agents: a meta-analysis.
Journal of chemotherapy (Florence, Italy) 2019 Dec 1-8.
Liang Xiaojun, Shen J
| Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis.
Cancer medicine 2019 Dec .
Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly
| The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics.
Cancer medicine 2019 Aug .
Bylsma Lauren C, Dean Rebecca, Lowe Kimberly, Sangaré Laura, Alexander Dominik D, Fryzek Jon
| Impact of primary colorectal Cancer location on the KRAS status and its prognostic value.
BMC gastroenterology 2019 Mar 19 (1): 46.
Xie Ming-Zhi, Li Ji-Lin, Cai Zheng-Min, Li Ke-Zhi, Hu Bang-
| PD-L1 expression and its effect on clinical outcomes of EGFR-mutant NSCLC patients treated with EGFR-TKIs.
Cancer biology & medicine 2018 Nov 15 (4): 434-442.
Bai Yuchen, Chen Xiaoxia, Hou Likun, Qian Jun, Jiang Tao, Zhou Caicun, Ciebiada Maci
| Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis.
Oncotarget 2018 Jan 9 (7): 7684-7699.
Lan Bo, Ma Chengxi, Zhang Chengyan, Chai Shoujie, Wang Pingli, Ding Liren, Wang K
| Mutations of key driver genes in colorectal cancer progression and metastasis.
Cancer metastasis reviews 2018 Jan .
Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong
| Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis.
Cancer management and research 2018 10 2915-2924.
Chen Duke, Wu Yu-Shen, Lin Huapeng, Wang Yihan, Li Longhao, Zhang T
| Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer.
Clinical and translational gastroenterology 2017 Oct 8 (10): e124.
Staudacher Jonas J, Yazici Cemal, Bul Vadim, Zeidan Joseph, Khalid Ahmer, Xia Yinglin, Krett Nancy, Jung Barba
| Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis.
Medicine 2017 Sep 96 (35): e7882.
Kwak Min Seob, Cha Jae Myung, Yoon Jin Young, Jeon Jung Won, Shin Hyun Phil, Chang Hye Jung, Kim Hyung Kyung, Joo Kwang Ro, Lee Joung
| The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis.
Oncotarget 2017 (32): 53631-53641.
Cao De-Dong, Xu Hui-Lin, Xu Xi-Ming, Ge W
| A systematic and genome-wide correlation meta-analysis of PD-L1 expression and targetable NSCLC driver genes.
Journal of thoracic disease 2017 Aug 9 (8): 2560-2571.
Li Jin, Chen Yaoqi, Shi Xiaoshun, Le Xiaobing, Feng Fenglan, Chen Jingyi, Zhou Chengzhi, Chen Yusong, Wen Shuai, Zeng Haikang, Chen Allen M, Zhang
| Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis.
The oncologist 2017 Aug .
Spindler Karen-Lise G, Boysen Anders K, Pallisgård Niels, Johansen Julia S, Tabernero Josep, Sørensen Morten M, Jensen Benny V, Hansen Torben F, Sefrioui David, Andersen Rikke F, Brandslund Ivan, Jakobsen Ande
| Prognostic value of EGFR and KRAS in circulating tumor DNA in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis.
Oncotarget 2017 May 8 (20): 33922-33932.
Fan Gaowei, Zhang Kuo, Ding Jiansheng, Li Jinmi
| KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis.
Oncotarget 2017 Jan .
Du Lijun, Kim John J, Shen Jinhua, Chen Binrui, Dai Ni
| Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis.
OncoTargets and therapy 2017 10 945-953.
Hao Yi-Xin, Fu Qiang, Guo Yan-Yan, Ye Ming, Zhao Hui-Xia, Wang Qi, Peng Xiu-Mei, Li Qiu-Wen, Wang Ru-Liang, Xiao Wen-H
| Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis.
Oncotarget 2017 01 .
Du Xin-Ya, Hu Yuan-Yuan, Xie Chun, Deng Chun-Yan, Liu Cai-Yun, Luo Zhi-Guo, Niu Yu-Ming, Shen Mi
| The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis.
PloS one 2017 12 (8): e0182562.
Zhuang Rongyuan, Li Song, Li Qian, Guo Xi, Shen Feng, Sun Hong, Liu Tians
| Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta-analysis.
Journal of cancer research and therapeutics 2016 Dec 12 (Supplement): C191-C198.
Lin Li, Chen Guang-Yong, Xu Chun-Wei, Wang Hai-Yan, Wu Yong-Fang, Fang Mei-
| Retraction: Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta analysis.
Journal of cancer research and therapeutics 0 13 (1): 156.
Authors are not available